CC
Casdin Capital Portfolio holdings
AUM
$1.1B
This Quarter Return
-19.64%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$966M
AUM Growth
+$966M
(-9.6%)
Cap. Flow
+$97.8M
Cap. Flow
% of AUM
10.12%
Top 10 Holdings %
Top 10 Hldgs %
64.34%
Holding
33
New
2
Increased
11
Reduced
6
Closed
–
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$41M |
| 2 |
BLUE
bluebird bio
BLUE
|
$22M |
| 3 |
CareDx
CDNA
|
$18.1M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$14.3M |
| 5 |
Fulcrum Therapeutics
FULC
|
$5.61M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$8.87M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$4.02M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$2.95M |
| 4 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$2.09M |
| 5 |
Editas Medicine
EDIT
|
$1.48M |
Sector Composition
| 1 | Healthcare | 81.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNST
26
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $9.84M | 1.02% | 1,523,960 | – | – |
|
|
27
Editas Medicine
EDIT
$231M
| $9.44M | 0.98% | 415,000 -65,000 | -14% | -$1.48M |
|
28
Twist Bioscience
TWST
$1.63B
| $7.16M | 0.74% | 300,000 | – | – |
|
|
29
Fulcrum Therapeutics
FULC
$351M
| $5.61M | 0.58% | +844,285 | New | +$5.61M |
|
|
ORTX
30
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $3.68M | 0.38% | 310,000 +210,000 | +210% | +$2.49M |
|
|
DCPH
31
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.39M | 0.35% | +100,000 | New | +$3.39M |
|
|
TPTX
32
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.82M | 0.29% | 75,000 +15,000 | +25% | +$564K |
|
33
Stoke Therapeutics
STOK
$1.08B
| $2.79M | 0.29% | 130,000 +45,000 | +53% | +$967K |
|